Related Experiment Video

Updated: Jun 25, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

Epidemiology and gene markers of ulcerative colitis in the Chinese

Jun Yun1, Chang-Tai Xu, Bo-Rong Pan

  • 1Department of General Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, Shaanxi Province, China.

World Journal of Gastroenterology
|February 21, 2009
PubMed

Insights

Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, is influenced by genetics. Identifying new genes offers potential for targeted therapies and improved patient prognoses.

Area of Science:

  • Gastroenterology
  • Genetics
  • Immunology

Background:

  • Inflammatory bowel disease (IBD) encompasses ulcerative colitis (UC) and Crohn's disease (CD), affecting the digestive system with inflammation and bleeding.
  • While often diagnosed in childhood and adolescence, IBD can manifest in infancy, with most epidemiological data derived from adult studies.
  • Common symptoms include abdominal pain, fatigue, diarrhea, and cramping.

Purpose of the Study:

  • To summarize the role of genetic factors in Inflammatory Bowel Disease (IBD) susceptibility.
  • To highlight recently identified genes contributing to IBD pathogenesis.
  • To explore the potential of these genetic discoveries for therapeutic development and clinical assessment.

Main Methods:

  • Review of epidemiological data supporting genetic contributions to IBD.
  • Identification and characterization of numerous novel genes associated with IBD susceptibility.
  • Analysis of the potential clinical applications of identified genetic markers.

Main Results:

  • Genetic factors significantly influence susceptibility to IBD (UC and CD).
  • Numerous new genes, including TNF-308A, CARD15 (NOD2), and HLA class-II, have been linked to IBD pathogenesis.
  • These genetic findings hold promise for identifying new therapeutic targets.

Conclusions:

  • Genetic factors are crucial in the development of IBD.
  • The identification of novel IBD-associated genes provides a foundation for future research.
  • Characterizing these genes can lead to improved clinical assessment and targeted treatments for IBD patients.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...